Earnings Call · Q4 FY2021·2022-02-03

Q4 21EPS +18.42%·Rev n/aQ3 21EPS +12.90%·Rev n/aQ2 21EPS -2.96%·Rev n/aQ1 21EPS -13.04%·Rev n/a⚠ consensus missing

Merck & Co., Inc. MRK

Peter Dannenbaum — Investor Relations

Rob Davis — President and Chief Executive Officer

Caroline Litchfield — Chief Financial Officer

Dr. Dean Li — President of Merck Research Labs

−3.7%1d on move date−1.3% vs SPY3d−5.4%5d−6.7%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MRK calls or request research access.

More MRK calls Browse calls Request research access